首页> 美国卫生研究院文献>JIMD Reports >Parkinsonism in Phenylketonuria: A Consequence of Dopamine Depletion?
【2h】

Parkinsonism in Phenylketonuria: A Consequence of Dopamine Depletion?

机译:苯丙酮尿症的帕金森病:多巴胺消耗的后果?

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Phenylketonuria (PKU) is caused by a deficiency or inactivity of the enzyme phenylalanine hydroxylase that converts phenylalanine (Phe) to tyrosine (Tyr). It has been proposed that a reduction of brain Tyr levels, as well as reduced activity of the key regulatory enzyme of dopamine (DA) synthesis tyrosine hydroxylase, leads to a depletion in DA activity in patients with PKU. We report a case of a 56-year-old woman with an intellectual disability due to late diagnosis of PKU and parkinsonism, with a modest clinical response to levodopa therapy.We hypothesize that the signs of parkinsonism might be caused by the depletion of DA activity in the brain. Clinicians should be alert on parkinsonian symptoms in patients with PKU, particularly in those treated with agents that negatively influence DA transmission.
机译:苯丙酮尿症(PKU)是由将苯丙氨酸(Phe)转化为酪氨酸(Tyr)的苯丙氨酸羟化酶缺乏或缺乏活性引起的。已经提出,脑Tyr水平的降低以及多巴胺(DA)合成酪氨酸羟化酶的关键调节酶的活性降低,导致PKU患者的DA活性降低。我们报告了一例56岁的女性,该患者因PKU和帕金森病的晚期诊断而患有智力障碍,并且对左旋多巴疗法的临床反应不佳。我们假设帕金森氏症的征兆可能是由于DA活动衰竭所致在大脑中。对于PKU患者,尤其是那些对DA传播产生负面影响的药物治疗的患者,临床医生应警惕帕金森氏病症状。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号